| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 1517-1522, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
C Parravinci, M Corbellino, M Paulli, U Magrini, M Lazzarino, PS Moore and Y Chang
Department of Pathology, University of Milano, L. Sacco Hospital, Milan, Italy.
Castleman's disease is a rare B cell lymphoproliferative disorder related to excess interleukin-6 (IL-6)-like activity. Kaposi's sarcoma- associated herpesvirus (KSHV or HHV8), which encodes a functional cytokine (vIL-6), has been found in some patients with Castleman's disease. Lymph nodes from 14 HIV-seronegative Castleman's disease patients were compared to hyperplastic lymph nodes from 25 HIV- seronegative patients as well as Kaposi's sarcoma lesions from 48 patients for KSHV infection and vIL-6, human IL-6, and Epstein-Barr virus EBER expression. While all Kaposi's sarcoma tissues examined were polymerase chain reaction-positive and all control lymph nodes were polymerase chain reaction-negative for KSHV, none had detectable vIL-6 expression. Six of 14 (43%) Castleman's tissues were positive for KSHV by polymerase chain reaction and all 6 had evidence of vIL-6 expression by immunohistochemistry. vIL-6-positive Castleman's disease patients generally had the multicentric plasma cell variant form of the disease and had a rapidly fatal clinical course frequently associated with autoimmune hemolytic anemia and gammopathy. In contrast, 7 (88%) of the 8 vIL-6-negative Castleman's disease patients had localized disease and have remained disease-free after therapy. KSHV vIL-6 expression appears to be limited to hematopoietic cells and is not present in Kaposi's sarcoma spindle cells. These data suggest that Castleman's disease is a syndrome of multiple etiologies involving aberrant IL-6 activity from either endogenous or viral sources.
This article has been cited by other articles:
 |
|
 |
|
  Y.-J. Zhang, R. S. Bonaparte, D. Patel, D. A. Stein, and P. L. Iversen Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus Mol. Cancer Ther., March 1, 2008; 7(3): 712 - 720. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sander, A. Konrad, M. Thurau, E. Wies, R. Leubert, E. Kremmer, H. Dinkel, T. Schulz, F. Neipel, and M. Sturzl Intracellular Localization Map of Human Herpesvirus 8 Proteins J. Virol., February 15, 2008; 82(4): 1908 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Taraseviciene-Stewart, M. R. Nicolls, D. Kraskauskas, R. Scerbavicius, N. Burns, C. Cool, K. Wood, J. E. Parr, S. A. Boackle, and N. F. Voelkel Absence of T Cells Confers Increased Pulmonary Arterial Hypertension and Vascular Remodeling Am. J. Respir. Crit. Care Med., June 15, 2007; 175(12): 1280 - 1289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Hagen, K. Fagan, W. Steudel, M. Carr, K. Lane, D. M. Rodman, and J. West Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1473 - L1479. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kovaleva, I. Bussmeyer, B. Rabe, J. Grotzinger, E. Sudarman, J. Eichler, U. Conrad, S. Rose-John, and J. Scheller Abrogation of Viral Interleukin-6 (vIL-6)-Induced Signaling by Intracellular Retention and Neutralization of vIL-6 with an Anti-vIL-6 Single-Chain Antibody Selected by Phage Display. J. Virol., September 1, 2006; 80(17): 8510 - 8520. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Nicolls, L. Taraseviciene-Stewart, P. R. Rai, D. B. Badesch, and N. F. Voelkel Autoimmunity and pulmonary hypertension: a perspective Eur. Respir. J., December 1, 2005; 26(6): 1110 - 1118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. S. Barton, M. L. Lutzke, R. Rochford, and H. W. Virgin IV Alpha/Beta Interferons Regulate Murine Gammaherpesvirus Latent Gene Expression and Reactivation from Latency J. Virol., November 15, 2005; 79(22): 14149 - 14160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Meads and P. G. Medveczky Kaposi's Sarcoma-associated Herpesvirus-encoded Viral Interleukin-6 Is Secreted and Modified Differently Than Human Interleukin-6: EVIDENCE FOR A UNIQUE AUTOCRINE SIGNALING MECHANISM J. Biol. Chem., December 10, 2004; 279(50): 51793 - 51803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. KLOUCHE, G. CARRUBA, L. CASTAGNETTA, and S. ROSE-JOHN Virokines in the Pathogenesis of Cancer: Focus on Human Herpesvirus 8 Ann. N.Y. Acad. Sci., December 1, 2004; 1028(1): 329 - 339. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-H. Deng, Y.-J. Zhang, X.-P. Wang, and S.-J. Gao Lytic Replication-Defective Kaposi's Sarcoma-Associated Herpesvirus: Potential Role in Infection and Malignant Transformation J. Virol., October 15, 2004; 78(20): 11108 - 11120. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Glaunsinger and D. Ganem Highly Selective Escape from KSHV-mediated Host mRNA Shutoff and Its Implications for Viral Pathogenesis J. Exp. Med., August 2, 2004; 200(3): 391 - 398. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Chatterjee, J. Osborne, G. Bestetti, Y. Chang, and P. S. Moore Viral IL-6-Induced Cell Proliferation and Immune Evasion of Interferon Activity Science, November 15, 2002; 298(5597): 1432 - 1435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. V. Ablashi, L. G. Chatlynne, J. E. Whitman Jr., and E. Cesarman Spectrum of Kaposi's Sarcoma-Associated Herpesvirus, or Human Herpesvirus 8, Diseases Clin. Microbiol. Rev., July 1, 2002; 15(3): 439 - 464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Oksenhendler, E. Boulanger, L. Galicier, M.-Q. Du, N. Dupin, T. C. Diss, R. Hamoudi, M.-T. Daniel, F. Agbalika, C. Boshoff, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease Blood, April 1, 2002; 99(7): 2331 - 2336. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Q. Du, H. Liu, T. C. Diss, H. Ye, R. A. Hamoudi, N. Dupin, V. Meignin, E. Oksenhendler, C. Boshoff, and P. G. Isaacson Kaposi sarcoma-associated herpesvirus infects monotypic (IgM{lambda}) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders Blood, April 1, 2001; 97(7): 2130 - 2136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Aoki, R. Yarchoan, K. Wyvill, S.-i. Okamoto, R. F. Little, and G. Tosato Detection of viral interleukin-6 in Kaposi sarcoma-associated herpesvirus-linked disorders Blood, April 1, 2001; 97(7): 2173 - 2176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Moore The Emergence of Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) N. Engl. J. Med., November 9, 2000; 343(19): 1411 - 1413. [Full Text]
|
|
|
|
|
|
E. Oksenhendler, G. Carcelain, Y. Aoki, E. Boulanger, A. Maillard, J.-P. Clauvel, and F. Agbalika High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients Blood, September 15, 2000; 96(6): 2069 - 2073. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-G. Judde, V. Lacoste, J. Briere, E. Kassa-Kelembho, E. Clyti, P. Couppie, C. Buchrieser, M. Tulliez, J. Morvan, and A. Gessain Monoclonality or Oligoclonality of Human Herpesvirus 8 Terminal Repeat Sequences in Kaposi's Sarcoma and Other Diseases J Natl Cancer Inst, May 3, 2000; 92(9): 729 - 736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J O'Leary, M Kennedy, D Howells, I Silva, V Uhlmann, K Luttich, S Biddolph, S Lucas, J Russell, N Bermingham, et al. Cellular localisation of HHV-8 in Castleman's disease: is there a link with lymph node vascularity? Mol. Pathol., April 1, 2000; 53(2): 69 - 76. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. Parravicini, B. Chandran, M. Corbellino, E. Berti, M. Paulli, P. S. Moore, and Y. Chang Differential Viral Protein Expression in Kaposi’s Sarcoma-Associated Herpesvirus-Infected Diseases : Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease Am. J. Pathol., March 1, 2000; 156(3): 743 - 749. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Damania, J.-K. Choi, and J. U. Jung Signaling Activities of Gammaherpesvirus Membrane Proteins J. Virol., February 15, 2000; 74(4): 1593 - 1601. [Full Text]
|
|
|
|
|
|
K. G. Mansfield, S. V. Westmoreland, C. D. DeBakker, S. Czajak, A. A. Lackner, and R. C. Desrosiers Experimental Infection of Rhesus and Pig-Tailed Macaques with Macaque Rhadinoviruses J. Virol., December 1, 1999; 73(12): 10320 - 10328. [Abstract] [Full Text]
|
|
|
|
|
|
K. D. Jones, Y. Aoki, Y. Chang, P. S. Moore, R. Yarchoan, and G. Tosato Involvement of Interleukin-10 (IL-10) and Viral IL-6 in the Spontaneous Growth of Kaposi's Sarcoma Herpesvirus-Associated Infected Primary Effusion Lymphoma Cells Blood, October 15, 1999; 94(8): 2871 - 2879. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Luppi, P. Barozzi, A. Maiorana, R. Trovato, R. Marasca, M. Morselli, K. Cagossi, and G. Torelli Expression of Cell-Homologous Genes of Human Herpesvirus-8 in Human Immunodeficiency Virus-Negative Lymphoproliferative Diseases Blood, October 15, 1999; 94(8): 2931 - 2933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Wong, E. P. Bergquam, R. M. Swanson, F. W. Lee, S. M. Shiigi, N. A. Avery, J. W. Fanton, and M. K. Axthelm Induction of B Cell Hyperplasia in Simian Immunodeficiency Virus–infected Rhesus Macaques with the Simian Homologue of Kaposi's Sarcoma–associated Herpesvirus J. Exp. Med., September 20, 1999; 190(6): 827 - 840. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Aoki, E. S. Jaffe, Y. Chang, K. Jones, J. Teruya-Feldstein, P. S. Moore, and G. Tosato Angiogenesis and Hematopoiesis Induced by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Interleukin-6 Blood, June 15, 1999; 93(12): 4034 - 4043. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Belec, A. S. Mohamed, F.-J. Authier, M.-C. Hallouin, A. M. Soe, S. Cotigny, P. Gaulard, and R. K. Gherardi Human Herpesvirus 8 Infection in Patients With POEMS Syndrome-Associated Multicentric Castleman's Disease Blood, June 1, 1999; 93(11): 3643 - 3653. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Staskus, R. Sun, G. Miller, P. Racz, A. Jaslowski, C. Metroka, H. Brett-Smith, and A. T. Haase Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi's Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman's Disease J. Virol., May 1, 1999; 73(5): 4181 - 4187. [Abstract] [Full Text]
|
|
|
|
|
|
R. Sarid, J. S. Wiezorek, P. S. Moore, and Y. Chang Characterization and Cell Cycle Regulation of the Major Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8) Latent Genes and Their Promoter J. Virol., February 1, 1999; 73(2): 1438 - 1446. [Abstract] [Full Text]
|
|
|
|
|
|
D. Jones, M. E. Ballestas, K. M. Kaye, J. M. Gulizia, G. L. Winters, J. Fletcher, D. T. Scadden, and J. C. Aster Primary-Effusion Lymphoma and Kaposi's Sarcoma in a Cardiac-Transplant Recipient N. Engl. J. Med., August 13, 1998; 339(7): 444 - 449. [Full Text] [PDF]
|
|
|
|
 |
|
 C. Lebbe Human Herpesvirus 8 as the Infectious Cause of Kaposi Sarcoma: Evidence and Involvement of Cofactors Arch Dermatol, June 1, 1998; 134(6): 736 - 738. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
